menu
    • menu

    Company profile for Galderma

    NEW Drugs in Dev: 35
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of...
    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GaldermaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    World Trade Center, Avenue Gratta-Paille 2, 1018 Lausanne
    Telephone
    Telephone
    +41 21 642 78 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galderma-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galderma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Village de la Chimie

    Not Confirmed

    envelop Contact Supplier

    Village de la Chimie

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galderma Announces Appointment Of New Chief Financial Officer
    Galderma Announces Appointment Of New Chief Financial Officer

    16 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-16/galderma-announces-appointment-of-new-chief-financial-officer

    PHARMIWEB
    16 Feb 2026
    Share Share
    Galderma Launches Restylane OBT Hyaluronic Acid Injectables
    Galderma Launches Restylane OBT Hyaluronic Acid Injectables

    11 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210555523/en/Galderma-Expands-Restylane-Portfolio-in-Japan-With-Launch-of-OBT-Hyaluronic-Acid-Injectables-Restylane-Defyne-and-Refyne

    BUSINESSWIRE
    11 Feb 2026
    Share Share
    Galderma Announces FDA BLA Acceptance Of RelabotulinumtoxinA
    Galderma Announces FDA BLA Acceptance Of RelabotulinumtoxinA

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260201157212/en/Galderma-Announces-U.S.-FDA-Acceptance-of-RelabotulinumtoxinA-Biologics-License-Application-Resubmission

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Galderma Addresses Menopause Skin Changes Via Global Survey
    Galderma Addresses Menopause Skin Changes Via Global Survey

    30 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129610958/en/Galderma-Tackles-Menopause-related-Skin-Changes-With-Global-Survey-and-Clinical-Trial-Inclusivity

    BUSINESSWIRE
    30 Jan 2026
    Share Share
    Galderma Launches 'Wake Up to Restylane' HA Campaign
    Galderma Launches 'Wake Up to Restylane' HA Campaign

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128829353/en/Galderma-Unveils-Wake-Up-To-Restylane-Underscoring-Restylane-as-the-Ideal-Hyaluronic-Acid-Treatment-for-Always-On-Natural-Beauty

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Galderma Showcases Broadest Injectables Portfolio at IMCAS 2026
    Galderma Showcases Broadest Injectables Portfolio at IMCAS 2026

    22 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260121547346/en/IMCAS-2026-Galderma-Showcases-the-Latest-Scientific-Advances-Behind-the-Industrys-Broadest-Injectable-Aesthetics-Portfolio

    BUSINESSWIRE
    22 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search